Alpha Tau Medical Ltd.
| NASDAQ: DRTS | Healthcare / Biotechnology / USA |
| 2.78 | -0.0300 | -1.07% | Vol 28.77K | 1Y Perf -81.14% |
| Mar 24th, 2023 15:59 DELAYED |
| BID | 2.76 | ASK | 3.02 | ||
| Open | 2.82 | Previous Close | 2.81 | ||
| Pre-Market | - | After-Market | - | ||
| - - | - -% |
| Target Price | 18.50 | Analyst Rating | Strong Buy 1.00 | |
| Potential % | 565.47 | Finscreener Ranking | — - | |
| Insiders Trans % 3/6/12 mo. | -/-/- | Value Ranking | — - | |
| Insiders Value % 3/6/12 mo. | -/-/- | Growth Ranking | — - | |
| Insiders Shares Cnt. % 3/6/12 mo. | -/-/- | Income Ranking | — - | |
| Price Range Ratio 52W % | -0.11 | Earnings Rating | — | |
| Market Cap | 192.19M | Earnings Date | 27th Mar 2023 | |
| Alpha | 0.00 | Standard Deviation | 0.10 | |
| Beta | 0.32 |
Today's Price Range 2.772.85 | 52W Range 2.8020.65 |
Summary:
Sell
| Technical Indicators: | Sell |
| Moving Averages: | Strong Sell |
| Performance | |||
|---|---|---|---|
| 1 Week | -7.33% | ||
| 1 Month | -10.61% | ||
| 3 Months | -8.85% | ||
| 6 Months | -52.48% | ||
| 1 Year | -81.14% | ||
| 3 Years | - | ||
| 5 Years | - | ||
| 10 Years | - |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | - | |||
ROE last 12 Months | -31.84 | |||
ROA (5Y Avg) | - | |||
ROA last 12 Months | -28.61 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | -31.84 | |||
Return on invested Capital Q | -2.43 | |||
Return on invested Capital Y | - | |||
Assets Turnover | 0.00 | |||
Receivables Turnover | 0.00 |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -5.00 | ||||
| 2.16 | ||||
| - | ||||
| - | ||||
| -33.60 | ||||
| -0.22 | ||||
| 2.16 | ||||
| 1.55 | ||||
| 123.52M | ||||
| Forward PE | - | |||
| PEG | - |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 32.10 | ||||
| 33.20 | ||||
| - | ||||
| - | ||||
| - | ||||
| Leverage Ratio | 1.20 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| - |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 0.00 | ||||
| 0.00 | ||||
| - | ||||
| - |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| Payout ratio | - |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q04 2022 | -0.12 | -0.04 | 66.67 |
| Q03 2022 | -0.10 | -0.04 | 60.00 |
| Q02 2022 | -0.10 | -0.03 | 70.00 |
| Q01 2022 | -0.10 | -0.54 | -440.00 |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| Next Report Date | 27th Mar 2023 |
| Estimated EPS Next Report | -0.12 |
| Estimates Count | 1 |
| EPS Growth Next 5 Years % | - |
| Volume Overview | |
|---|---|
| Volume | 28.77K |
| Shares Outstanding | 69.13K |
| Shares Float | 33.98M |
| Trades Count | 241 |
| Dollar Volume | 80.92K |
| Avg. Volume | 57.04K |
| Avg. Weekly Volume | 57.58K |
| Avg. Monthly Volume | 40.40K |
| Avg. Quarterly Volume | 73.15K |
Alpha Tau Medical Ltd. (NASDAQ: DRTS) stock closed at 2.78 per share at the end of the most recent trading day (a -1.07% change compared to the prior day closing price) with a volume of 28.77K shares and market capitalization of 192.19M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 0 people. Alpha Tau Medical Ltd. CEO is .
The one-year performance of Alpha Tau Medical Ltd. stock is -81.14%, while year-to-date (YTD) performance is -12.58%. DRTS stock has a five-year performance of %. Its 52-week range is between 2.8 and 20.65, which gives DRTS stock a 52-week price range ratio of -0.11%
Alpha Tau Medical Ltd. currently has a PE ratio of -5.00, a price-to-book (PB) ratio of 2.16, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -28.61%, a ROC of -31.84% and a ROE of -31.84%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.
Of the last four earnings reports from Alpha Tau Medical Ltd., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.12 for the next earnings report. Alpha Tau Medical Ltd.’s next earnings report date is 27th Mar 2023.
The consensus rating of Wall Street analysts for Alpha Tau Medical Ltd. is Strong Buy (1), with a target price of $18.5, which is +565.47% compared to the current price. The earnings rating for Alpha Tau Medical Ltd. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Alpha Tau Medical Ltd. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Alpha Tau Medical Ltd. has a Sell technical analysis rating based on Technical Indicators (ADX : 30.17, ATR14 : 0.22, CCI20 : -153.24, Chaikin Money Flow : -0.47, MACD : -0.18, Money Flow Index : 20.69, ROC : -15.24, RSI : 33.58, STOCH (14,3) : 1.14, STOCH RSI : 0.00, UO : 14.95, Williams %R : -98.86), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Alpha Tau Medical Ltd. in the last 12-months were:
